Tyler Bussian
Stock Analyst at Brookline Capital
(n/a)
# 3,996
Out of 4,789 analysts
5
Total ratings
n/a
Success rate
-46.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.37 | +556.93% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $12.69 | +396.65% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.13 | +784.96% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $1.57 | +475.08% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.37
Upside: +556.93%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $12.69
Upside: +396.65%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.13
Upside: +784.96%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $1.57
Upside: +475.08%